Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Roth, Carina ^a   Stückrath, Isabel ^a   Pantel, Klaus ^a   Izbicki, Jakob R ^a   Tachezy, Michael ^a   Schwarzenbach, Heidi ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MIR 361 3P; MIR 625; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; MIRN361 MICRORNA, HUMAN; MIRN625 MICRORNA, HUMAN; SMAD2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BIOCHIP; CANCER PATIENT; CELL STRAIN; CELL STRAIN A549; CIGARETTE SMOKING; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LARGE CELL LUNG CANCER; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MICROARRAY ANALYSIS; MICROFLUIDIC ANALYSIS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; BLOOD; CELL FREE SYSTEM; COHORT ANALYSIS; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HEALTH; METABOLISM; MIDDLE AGED; POSTOPERATIVE CARE; PREOPERATIVE CARE; REPRODUCIBILITY; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL-FREE SYSTEM; COHORT STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEALTH; HUMANS; LUNG NEOPLASMS; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POSTOPERATIVE CARE; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMAD2 PROTEIN; SMOKING; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL;

EID: 84861853799     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038248     Document Type: Article

References (34)

1. Alberg AJ, Samet JM, (2003) Epidemiology of lung cancer. Chest 123: 21S-49S.
2. Planchard D, Le Pechoux C, (2011) Small cell lung cancer: new clinical recommendations and current status of biomarker assessment. Eur J Cancer 47 (Suppl 3): S272-283.
3. Alberg AJ, Brock MV, Samet JM, (2005) Epidemiology of lung cancer: looking to the future. J Clin Oncol 23: 3175-3185.
4. Cohen EE, Subramanian J, Gao F, Szeto L, Kozloff M, et al. (2012) Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial. Clin Lung Cancer 13: 123-128.
5. Gao W, Liu L, Lu X, Shu Y, (2011) Circulating MicroRNAs: Possible Prediction Biomarkers for Personalized Therapy of Non-Small-Cell Lung Carcinoma. Clin Lung Cancer 12: 14-17.
6. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
7. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
8. Vasudevan S, Tong Y, Steitz JA, (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318: 1931-1934.
9. Kloosterman WP, Plasterk RH, (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450.
10. Stefani G, Slack FJ, (2008) Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9: 219-230.
11. Xu P, Guo M, Hay BA, (2004) MicroRNAs and the regulation of cell death. Trends Genet 20: 617-624.
12. Iorio MV, Croce CM, (2009) MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27: 5848-5856.
13. Liu X, Sempere LF, Guo Y, Korc M, Kauppinen S, et al. (2011) Involvement of microRNAs in lung cancer biology and therapy. Transl Res 157: 200-208.
14. Huang Z, Huang D, Ni S, Peng Z, Sheng W, et al. (2009) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118-126.
15. Roth C, Rack B, Muller V, Janni W, Pantel K, et al. (2010) Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 12: R90.
16. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ, (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-144.
17. Muratovska A, Zhou C, He S, Goodyer P, Eccles MR, (2003) Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 22: 7989-7997.
18. Ehrhardt A, Ehrhardt GR, Guo X, Schrader JW, (2002) Ras and relatives-job sharing and networking keep an old family together. Exp Hematol 30: 1089-1106.
19. Feng ZJ, Gao SB, Wu Y, Xu XF, Hua X, et al. (2010) Lung cancer cell migration is regulated via repressing growth factor PTN/RPTP beta/zeta signaling by menin. Oncogene 29: 5416-5426.
20. Liu YJ, Xu Y, Yu Q, (2006) Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively. Oncogene 25: 2452-2467.
21. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, et al. (2003) Dicer is essential for mouse development. Nat Genet 35: 215-217.
22. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, et al. (2009) A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 41: 365-370.
23. Davidson MR, Larsen JE, Yang IA, Hayward NK, Clarke BE, et al. (2010) MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLoS One 5: e12560.
24. Gao W, Yu Y, Cao H, Shen H, Li X, et al. (2010) Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother 64: 399-408.
25. Schembri F, Sridhar S, Perdomo C, Gustafson AM, Zhang X, et al. (2009) MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci U S A 106: 2319-2324.
26. Sun S, Schiller JH, Gazdar AF, (2007) Lung cancer in never smokers-a different disease. Nat Rev Cancer 7: 778-790.
27. Elliott RL, Blobe GC, (2005) Role of transforming growth factor Beta in human cancer. J Clin Oncol 23: 2078-2093.
28. Wu YY, Peck K, Chang YL, Pan SH, Cheng YF, et al. (2011) SCUBE3 is an endogenous TGF-beta receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer. Oncogene 30: 3682-3693.
29. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
30. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
31. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, et al. (2011) miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 6: 482-488.
32. Hu Z, Chen X, Zhao Y, Tian T, Jin G, et al. (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28: 1721-1726.
33. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, et al. (2011) Circulating microRNA expression profiles in early stage non-small cell lung cancer. Int J Cancer.
34. Bianchi F, Nicassio F, Marzi M, Belloni E, Dall'olio V, et al. (2011) A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med.